Literature DB >> 25392334

We can compare the relative efficacy of multiple sclerosis medications by examining the results of independent clinical trials: no.

Olga Ciccarelli1, Jeremy Chataway2.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25392334     DOI： 10.1177/1352458514559866

Source DB:  PubMed          Journal:  Mult Scler        ISSN： 1352-4585            Impact factor:   6.312


× No keyword cloud information.
  1 in total

1.  Oral Disease-Modifying Treatments for Relapsing Multiple Sclerosis: A Likelihood to Achieve No Evidence of Disease Activity or Harm Analysis.

Authors:  Dimitrios Papadopoulos; Dimos-Dimitrios D Mitsikostas
Journal:  CNS Drugs       Date:  2018-11       Impact factor: 5.749
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.